Literature DB >> 21820971

Recommendation to revise the AJCC/UICC breast cancer staging system for inclusion of proven prognostic factors: ER/PR receptor status and HER2 neu.

Vijayashree Murthy, Ronald S Chamberlain.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21820971     DOI： 10.1016/j.clbc.2011.05.003

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN： 1526-8209            Impact factor:   3.225


× No keyword cloud information.
  3 in total

1.  Impact of polysomy 17 on HER2 testing of invasive breast cancer patients.

Authors:  Yang Liu; Li Ma; Dequan Liu; Zhibing Yang; Chengang Yang; Zaoxiu Hu; Wenlin Chen; Zhuangqing Yang; Sijun Chen; Zhuoni Zhang
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

Review 2.  Inflammatory breast cancer: a proposed conceptual shift in the UICC-AJCC TNM staging system.

Authors:  Tamer M Fouad; Angelica M Gutierrez Barrera; James M Reuben; Anthony Lucci; Wendy A Woodward; Michael C Stauder; Bora Lim; Sarah M DeSnyder; Banu Arun; Babiera Gildy; Vicente Valero; Gabriel N Hortobagyi; Naoto T Ueno
Journal:  Lancet Oncol       Date:  2017-04       Impact factor: 41.316

3.  Radiation therapy following surgery for localized breast cancer: outcome prediction by classical prognostic factors and approximated genetic subtypes.

Authors:  Roberto Pacelli; Manuel Conson; Laura Cella; Raffaele Liuzzi; Giancarlo Troncone; Vincenzo Iorio; Raffaele Solla; Antonio Farella; Stefania Scala; Clorindo Pagliarulo; Marco Salvatore
Journal:  J Radiat Res       Date:  2012-09-26       Impact factor: 2.724
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.